Collegium Pharmaceutical, Inc. (COLL) Gross margin 2016–2025
Collegium Pharmaceutical, Inc. (COLL) gross margin by fiscal year — reported gross profit divided by reported revenue.
59.3%FY2025 · since FY2016: 87.6% → 59.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 59.3% | -0.4 pp |
| FY2024 | 59.8% | +2.2 pp |
| FY2023 | 57.5% | +12.4 pp |
| FY2022 | 45.2% | -9.2 pp |
| FY2021 | 54.4% | -3.6 pp |
| FY2020 | 58.0% | +23.3 pp |
| FY2019 | 34.7% | -6.2 pp |
| FY2018 | 40.9% | -50.0 pp |
| FY2017 | 90.9% | +3.3 pp |
| FY2016 | 87.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More COLL financial trends
COLL RevenueCOLL Net incomeCOLL Net marginCOLL Gross profitCOLL Operating incomeCOLL Operating marginCOLL Operating cash flowCOLL Free cash flowCOLL Capital expendituresCOLL Return on equityCOLL Stock buybacksCOLL Dividends paidCOLL Total assetsCOLL Total liabilitiesCOLL Shareholders’ equityCOLL overview →